• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Mobile App Improves Pain Medication Adherence in Advanced Cancer

by
November 8, 2026
in Health, Technology
Reading Time: 6 mins read
0
Mobile App Improves Pain Medication Adherence in Advanced Cancer

Mobile App Improves Pain Medication Adherence in Advanced Cancer

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A randomized controlled trial conducted at the All India Institute of Medical Sciences in New Delhi has demonstrated that a mobile application-based prescription system significantly improves medication adherence, health knowledge, and patient satisfaction among individuals with advanced cancer receiving palliative care. The study, published in BMC Digital Health, evaluated the effectiveness of the UPPCHAR app, which integrates health education with prescription management, against a conventional prescription method accompanied by a printed educational booklet. The research indicates that digital health tools can serve as effective adjuncts in managing complex pain regimens for patients with stage 3 or 4 cancer, addressing a critical gap in palliative care delivery in resource-constrained settings.

The central finding of the trial is that patients using the mobile app-based prescription (MABP) system exhibited significantly better compliance with their analgesic and adjuvant medications compared to those receiving conventional prescriptions (CP). After a six-month intervention period, the MABP group showed a mean adherence score of 17.79, whereas the CP group recorded a mean score of 23.99 on the Adherence to Refills and Medication Scale. Lower scores on this scale indicate better adherence, meaning the mobile app group demonstrated a statistically significant improvement in taking their medications as prescribed. This outcome was consistent across both unadjusted and adjusted analyses, with the adjusted difference in mean scores being 6.38, reinforcing the robustness of the intervention’s impact on medication behavior.

The study was designed as a randomized controlled trial involving 204 eligible patients with biopsy-proven advanced cancer who were receiving palliative care at the Pain and Palliative Care clinic. Participants were randomly allocated to either the MABP group or the CP group using block randomization with varying block sizes, ensuring that both groups were comparable in terms of baseline demographic and clinical profiles. Inclusion criteria required patients to be over 18 years old, have access to an Android smartphone, and be willing to participate in the study. Exclusion criteria included a life expectancy of less than six months, cognitive impairments, psychiatric illnesses, or the inability to read English or Hindi, ensuring that the study population could effectively engage with the digital intervention and understand the educational content.

The UPPCHAR app, which stands for Understanding Pain and Palliative Care, Health and Rehabilitation, was the second version of a mobile application developed specifically for cancer patients in palliative care. Unlike basic prototypes that merely provided medication reminders, this enhanced version incorporated symptom-driven health education. When patients reported moderate to severe symptoms through the app, the system automatically directed them to relevant educational content specific to that symptom, providing just-in-time support. This feature aimed to address common barriers to adherence, such as fear of side effects, poor knowledge of pain management, and complex dosing schedules, by offering personalized and context-specific information at the moment of need.

In contrast, the control group received routine care along with a static educational booklet on cancer pain and its management. This booklet provided general information about pain mechanisms, medication side effects, and management strategies but lacked the interactive and dynamic features of the mobile app. Both groups were followed up bimonthly for six months at the pain and palliative care outpatient department. Data collection occurred at baseline and at the six-month mark, using standardized tools to measure compliance, knowledge, and satisfaction. The study adhered to CONSORT guidelines for reporting randomized controlled trials, ensuring transparency in the participant flow and analysis methods.

Knowledge scores, measured by a structured questionnaire consisting of 24 multiple-choice items, also showed significant improvement in the MABP group. At baseline, there was no significant difference in knowledge between the two groups, with mean scores of 6.82 for the MABP group and 6.40 for the CP group. However, after six months, the MABP group achieved a mean knowledge score of 13.41, compared to 8.90 in the CP group. This substantial increase suggests that the app’s symptom-triggered educational modules were more effective in enhancing patient understanding of cancer pain and its management than the static booklet. The knowledge domains covered included the type of cancer pain, assessment methods, management strategies, drug side effects, and strategies for taking medications, providing a comprehensive educational framework for patients.

Patient satisfaction, assessed using the Patient Satisfaction Questionnaire (PSQ-18), was also higher in the MABP group across multiple dimensions after the intervention. The PSQ-18 measures satisfaction across seven areas: general satisfaction, technical quality, interpersonal manner, communication, financial aspects, time spent with doctors, and accessibility or convenience. While baseline satisfaction levels were comparable between the two groups, the MABP group reported significantly higher median scores in all subscales at six months. For instance, in the domain of accessibility and convenience, the MABP group had a median score of 3.25, whereas the CP group scored 2.25. This indicates that patients perceived the mobile app as a more convenient and accessible method for managing their care, likely due to the ease of accessing prescription details and educational resources on their smartphones.

The statistical analysis of the study utilized intention-to-treat and per-protocol analyses for the primary outcome of compliance and the first secondary outcome of knowledge. Missing values were imputed using the Last Observation Carried Forward method, and analysis of covariance (ANCOVA) was used to adjust for baseline variables that were not comparable between the groups, such as education, occupation, surgery history, and duration of analgesic intake. The use of ANCOVA ensured that the observed differences in outcomes could be attributed to the intervention rather than pre-existing disparities between the groups. Satisfaction was analyzed using the Wilcoxon rank sum test for between-group comparisons and the Wilcoxon signed rank test for within-group changes, accounting for the ordinal nature of the satisfaction scores.

One of the key strengths of this study is its randomized controlled design combined with a six-month follow-up period, which provides robust evidence on the long-term effects of the mobile app intervention. The sample size was calculated based on previous cross-sectional surveys indicating low adherence rates among cancer patients, ensuring sufficient statistical power to detect meaningful differences. The study was conducted in a single setting at a high-volume tertiary care center, which may limit the generalizability of the findings to other healthcare environments. Additionally, the app was compatible only with Android devices, which could restrict its accessibility for patients using iOS platforms. The resource-intensive nature of developing and maintaining a mobile app may also pose challenges for widespread adoption in resource-limited settings.

Despite these limitations, the study contributes valuable evidence to the growing body of research on mobile health interventions in palliative care. The findings suggest that integrating mobile apps into routine clinical workflows can enhance patient engagement, improve medication adherence, and increase patient satisfaction. The app’s ability to provide timely, context-specific educational support addresses a critical need for patients with advanced cancer who often face complex treatment regimens and significant symptom burden. Future studies should focus on multicentric trials involving larger and more diverse populations to further validate the effectiveness of such interventions and explore their impact on clinical outcomes such as pain intensity and quality of life.

The implications of this research extend beyond cancer pain management, suggesting that similar mobile health frameworks could be adapted for other chronic conditions requiring complex medication regimens and patient education. Integrating these apps with hospital electronic health records could facilitate real-time data sharing and improve continuity of care. However, stringent data privacy and security measures will be essential to build trust and ensure safe implementation. As mobile technology continues to evolve, the potential for digital health tools to support palliative care delivery becomes increasingly apparent, offering a promising avenue for improving patient outcomes and reducing the burden on healthcare systems.

In conclusion, the UPPCHAR mobile app demonstrated significant effectiveness in improving medication adherence, knowledge, and satisfaction among patients with advanced cancer receiving palliative care. The study highlights the potential of mobile health interventions to address common barriers to treatment adherence and enhance patient education. By leveraging the widespread availability of smartphones, healthcare providers can offer personalized support to patients, ensuring that they have access to the information and reminders they need to manage their conditions effectively. This research underscores the importance of integrating digital tools into palliative care practices to improve the quality of life for patients with advanced cancer.

Subject of Research: Effectiveness of mobile app-based prescriptions on compliance, knowledge, and satisfaction in advanced cancer palliative care

Article Title: Effectiveness of mobile app-based prescriptions of analgesics and adjuvants (UPPCHAR App with integrated Health Education) on compliance, knowledge and satisfaction among patients with advanced cancer receiving palliative care – a randomized controlled trial

Article References: Hote, P. K., Venkatesan, L., Garg, R., Chalga, M. S., Kalaivani, M., & Gopichandran, L. (2026). Effectiveness of mobile app-based prescriptions of analgesics and adjuvants (UPPCHAR App with integrated Health Education) on compliance, knowledge and satisfaction among patients with advanced cancer receiving palliative care – a randomized controlled trial. BMC Digital Health, 4(1), Article 55. https://doi.org/10.1186/s44247-026-00288-3

Image Credits: AI Generated

DOI: 10.1186/s44247-026-00288-3

Keywords: palliative care, mobile health, medication adherence, advanced cancer, randomized controlled trial, patient satisfaction, health education, digital health, Effectiveness, mobile, app-based, prescriptions

News Source: Nathaniel Bowman. (November 8, 2026). Mobile App Improves Pain Medication Adherence in Advanced Cancer. Scienmag.

Tags: advanced cancerapp-basedDigital Healtheffectivenesshealth educationMedication Adherencemobilemobile healthPalliative carepatient satisfactionprescriptionsrandomized controlled trial
Share12Tweet7Share2ShareShareShare1

Related Posts

Early ICU Plasma Transfusion Not Independently Linked to Postoperative Sepsis

Early ICU Plasma Transfusion Not Independently Linked to Postoperative Sepsis

November 17, 2026
Revised Gene Models Reveal Distinct Protein Synthesis Targets in Parasitic Helminths

Revised Gene Models Reveal Distinct Protein Synthesis Targets in Parasitic Helminths

November 17, 2026

Higher Dietary Fat Linked to Accelerated Neurodegeneration in Older Adults

November 17, 2026

Case Report Identifies Potential Association Between Maras Powder and Cerebral Thrombosis

November 17, 2026

POPULAR NEWS

  • Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

    Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

    29 shares
    Share 12 Tweet 7
  • Review Links Skin Microbiota and T-Cell Crosstalk to Venous Disease Progression

    29 shares
    Share 12 Tweet 7
  • Pre-Curing Rheology Enables Electrospun Silicone Elastomer Coatings for Cochlear Implants

    29 shares
    Share 12 Tweet 7
  • Solvothermal Synthesis Yields Bismuth Selenide Nanoparticles with Distinct Phonon Modes

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Early ICU Plasma Transfusion Not Independently Linked to Postoperative Sepsis

Revised Gene Models Reveal Distinct Protein Synthesis Targets in Parasitic Helminths

Review Finds Unproven MEKK3 Kinase Efficacy in Traumatic Spinal Cord Injury

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.